BerGenBio
Clinical-stage biopharma that developed selective AXL kinase inhibitors for cancer.
BGBIO | OL
Overview
Corporate Details
- ISIN(s):
- NO0012921180 (+2 more)
- LEI:
- 213800TYYFXKYF3V2A23
- Country:
- Norway
- Address:
- MØLLENDALSBAKKEN 9, 5009 BERGEN
- Website:
- https://www.bergenbio.com/
- Sector:
- Manufacturing
Description
BerGenBio was a clinical-stage biopharmaceutical company focused on developing first-in-class selective AXL kinase inhibitors. The company's therapeutic candidates targeted AXL as a potential cornerstone of therapy for aggressive, advanced, and treatment-resistant cancers. In October 2025, BerGenBio completed a merger with Oncoinvent ASA, and the combined entity was renamed Oncoinvent.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2017-04-06 06:13 |
BerGenBio ASA - Successful completion of initial public offering
|
English | 12.5 KB | ||
| 2017-04-05 06:20 |
BerGenBio ASA - Last day of application period
|
English | 8.9 KB | ||
| 2017-04-03 14:17 |
BerGenBio ASA - APPLICATIONS BY PRIMARY INSIDERS
|
English | 9.7 KB | ||
| 2017-04-03 07:45 |
BerGenBio's first-in-class Axl inhibitor, BGB324, featured in two immuno-oncolo…
|
English | 11.6 KB | ||
| 2017-03-31 07:35 |
The Board of Oslo Børs approves BerGenBio ASA for listing on Oslo Børs
|
English | 944 bytes | ||
| 2017-03-31 07:35 |
Styret ved Oslo Børs godkjenner BerGenBio ASA for notering på Oslo Børs
|
Norwegian | 804 bytes | ||
| 2017-03-31 06:10 |
BerGenBio ASA - Update on bookbuilding
|
English | 8.8 KB | ||
| 2017-03-30 06:48 |
BerGenBio ASA - APPLICATIONS BY PRIMARY INSIDERS
|
English | 10.4 KB | ||
| 2017-03-29 06:30 |
Received application for listing - BerGenBio ASA
|
English | 755 bytes | ||
| 2017-03-29 06:30 |
Mottatt søknad om notering - BerGenBio ASA
|
Norwegian | 638 bytes | ||
| 2017-03-29 06:18 |
BerGenBio ASA - Publication of prospectus and commencement of the application p…
|
English | 10.2 KB | ||
| 2017-03-28 14:22 |
Mottatt søknad om notering - BerGenBio ASA
|
Norwegian | 638 bytes | ||
| 2017-03-28 14:22 |
Received application for listing - BerGenBio ASA
|
English | 755 bytes | ||
| 2017-03-28 06:05 |
BerGenBio announces the terms of its Initial Public Offering
|
English | 14.8 KB | ||
| 2017-03-08 11:12 |
BerGenBio announces its intention to launch an Initial Public Offering and appl…
|
English | 12.6 KB |
Automate Your Workflow. Get a real-time feed of all BerGenBio filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BerGenBio
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BerGenBio via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
